Home > Insider Trading > Filing (0001179110-15-012247)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1583107	Theravance Biopharma Inc.	TBPH	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1607737	D Renee Gala	C/O Theravance Biopharma Us, Inc. 901 Gateway Blvd South San Francisco CA 94080	Svp, Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2015-08-13	5,000	$12.19	154,279	No	4	P	Direct
Ordinary Shares	Acquisiton	2015-08-17	5,000	$12.16	161,177	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

Represents the weighted average purchase price per share for the open market purchase on August 13, 2015. The shares were purchased at prices ranging from $12.18 to $12.20 per share. Full information regarding the number of shares purchased at each price shall be provided upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Represents the weighted average purchase price per share for the open market purchase on August 17, 2015. The shares were purchased at prices ranging from $12.12 to $12.24 per share. Full information regarding the number of shares purchased at each price shall be provided upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Includes 1,898 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2015.